PT946526E - Acidos carboxilicos macrociclicos complexos de metais sua utilizacao e processo para a sua preparacao - Google Patents

Acidos carboxilicos macrociclicos complexos de metais sua utilizacao e processo para a sua preparacao

Info

Publication number
PT946526E
PT946526E PT97952805T PT97952805T PT946526E PT 946526 E PT946526 E PT 946526E PT 97952805 T PT97952805 T PT 97952805T PT 97952805 T PT97952805 T PT 97952805T PT 946526 E PT946526 E PT 946526E
Authority
PT
Portugal
Prior art keywords
complex
carboxylic acids
preparation
metal complex
acids
Prior art date
Application number
PT97952805T
Other languages
English (en)
Inventor
Bernd Raduchel
Johannes Platzek
Heribert Schmitt-Willich
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT946526E publication Critical patent/PT946526E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/12Macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
PT97952805T 1996-12-04 1997-11-26 Acidos carboxilicos macrociclicos complexos de metais sua utilizacao e processo para a sua preparacao PT946526E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19652387A DE19652387A1 (de) 1996-12-04 1996-12-04 Macrocyclische Metallkomplexcarbonsäuren, ihre Verwendung sowie Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
PT946526E true PT946526E (pt) 2004-02-27

Family

ID=7814929

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97952805T PT946526E (pt) 1996-12-04 1997-11-26 Acidos carboxilicos macrociclicos complexos de metais sua utilizacao e processo para a sua preparacao

Country Status (16)

Country Link
EP (1) EP0946526B1 (pt)
JP (1) JP4252112B2 (pt)
KR (1) KR100495846B1 (pt)
CN (1) CN1100767C (pt)
AT (1) ATE253056T1 (pt)
AU (1) AU734983B2 (pt)
CA (1) CA2274132C (pt)
DE (2) DE19652387A1 (pt)
DK (1) DK0946526T3 (pt)
ES (1) ES2208968T3 (pt)
HK (1) HK1022153A1 (pt)
IL (1) IL130271A (pt)
PT (1) PT946526E (pt)
TW (1) TW434232B (pt)
WO (1) WO1998024774A1 (pt)
ZA (1) ZA9710931B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1369134A1 (en) 2002-06-05 2003-12-10 Bracco Imaging S.p.A. New agents for magnetic imaging method
DE102007058220A1 (de) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft Dimere macrocyclisch substituierte Benzolderivate
KR101334780B1 (ko) 2010-08-13 2013-12-02 한국생명공학연구원 요오드를 함유한 방사형상의 고분자 화합물, 이의 제조방법 및 이를 포함하는 ct용 조영제 조성물
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
KR102464647B1 (ko) 2016-11-28 2022-11-08 바이엘 파마 악티엔게젤샤프트 자기 공명 영상화에 사용하기 위한 높은 이완도 가돌리늄 킬레이트 화합물
JP2020517584A (ja) * 2017-04-27 2020-06-18 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 修飾mri造影剤およびその使用
AU2019382881A1 (en) 2018-11-23 2021-05-20 Bayer Aktiengesellschaft Formulation of contrast media and process of preparation thereof
CN114573521B (zh) * 2020-12-01 2023-10-27 威智医药股份有限公司 一种钆布醇及其中间体的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA894792B (en) * 1988-06-24 1991-04-24 Dow Chemical Co Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates
DE3938992A1 (de) * 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4009119A1 (de) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4344460A1 (de) * 1993-12-22 1995-06-29 Schering Ag Metallkomplexe von dendrimeren Makromolekülen, diese enthaltende diagnostische Mittel sowie Verfahren zur Herstellung der Komplexe und Mittel
DE4425857A1 (de) * 1994-07-07 1996-01-11 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE19525924A1 (de) * 1995-07-04 1997-01-09 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE19549286A1 (de) * 1995-12-22 1997-06-26 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel

Also Published As

Publication number Publication date
DE59710931D1 (de) 2003-12-04
AU5655498A (en) 1998-06-29
EP0946526A1 (de) 1999-10-06
AU734983B2 (en) 2001-06-28
CN1239958A (zh) 1999-12-29
IL130271A0 (en) 2000-06-01
KR100495846B1 (ko) 2005-06-17
JP4252112B2 (ja) 2009-04-08
WO1998024774A1 (de) 1998-06-11
CA2274132A1 (en) 1998-06-11
JP2001504843A (ja) 2001-04-10
EP0946526B1 (de) 2003-10-29
ES2208968T3 (es) 2004-06-16
ATE253056T1 (de) 2003-11-15
IL130271A (en) 2005-05-17
ZA9710931B (en) 1998-06-15
DE19652387A1 (de) 1998-06-10
CN1100767C (zh) 2003-02-05
DK0946526T3 (da) 2004-01-12
KR20000057402A (ko) 2000-09-15
CA2274132C (en) 2008-02-12
HK1022153A1 (en) 2000-07-28
TW434232B (en) 2001-05-16

Similar Documents

Publication Publication Date Title
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
ES2190469T3 (es) Derivados de isocumarina y su uso en farmacos.
TR200200416T2 (tr) İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
MX205459A (es) Agentes de contraste para resonancia magnetica nuclear y proceso para su preparacion
GR3004713T3 (pt)
BG102162A (en) Substituted (sulpphinic acid, sulphonic acid, sulphonylamino or sulphinylamino)n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylam ide compounds
RU94036004A (ru) Промежуточные соединения для получения ароматических аминоспиртовых производных
NO960115D0 (no) Monomere og multimere forbindelser med forsterket relaksivitet
DE69113155D1 (de) 17-beta-substituierte-4-aza-5-alpha-androstan-3-one-derivate und verfahren zu ihrer herstellung.
ES8702784A1 (es) Un procedimiento para preparar una composicion anticaspa a base de una sal de 1-hidroxi-2-piridintiona y una hidroxipiridona.
ATE169827T1 (de) Tetraazamakrocyclische metallkomplexe
DE69221563T2 (de) Polyfluoralkylthiopoly(ethylimidazolium)-Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als biozide Mittel
ATE69239T1 (de) Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung.
PT946526E (pt) Acidos carboxilicos macrociclicos complexos de metais sua utilizacao e processo para a sua preparacao
NO976098L (no) Metallkomplekser av polyaminosyrer og deres anvendelse innen avbildning for diagnoseformål
DE69410614D1 (de) Bis-naphthalimide für die behandlung von krebs
NO175745C (no) Analogifremgangsmåte for fremstilling av dibenzo(1,5)-dioksocin-5-oner
FI951760A0 (fi) Gestageenisesti vaikuttavat 19,11-silloitetut 4-estreenit
ES2021944A6 (es) Procedimiento para preparar nuevos derivados de 1,3,5,-triamino-2,4,6-triyodobenceno.
DE3560291D1 (en) 1-ûn-(alpha-amino-alpha-methylacetyl)-aminophenyl¨-2-amino propanon derivatives, process for their preparation and their therapeutical use
ES8301230A1 (es) Un procedimiento para la preparacion de 1-fenil-5-amidotetrazoles.